CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells

Author：                                    

Publisher： Spandidos Publications

E-ISSN： 1791-2423|46|4|1560-1572

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.46, Iss.4, 2015-01, pp. : 1560-1572

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage

By Li Lei  

Carcinogenesis, Vol. 34, Iss. 2, 2013-02 ,pp. : 257-267

Oxford University Press

Access to resources Recommend Favorite

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer

By Obinata Daisuke   Takayama Kenichi   Takahashi Satoru   Inoue Satoshi  

Cancers, Vol. 9, Iss. 3, 2017-02 ,pp. : 22-22

MDPI

Access to resources Recommend Favorite

Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-κB signaling pathway

By                    

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 375-381

Spandidos Publications

Access to resources Recommend Favorite

Docosahexaenoic acid inhibits the growth of hormone-dependent prostate cancer cells by promoting the degradation of the androgen receptor

By                    

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3769-3774

Spandidos Publications

Access to resources Recommend Favorite

Shikonin inhibits the growth of human prostate cancer cells via modulation of the androgen receptor

By        

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1455-1460

Spandidos Publications

Access to resources Recommend Favorite